Skip to main content

Table 3 Characteristics and treatment history of the simulated population of patients with ankylosing spondylitis on January 1, 2014

From: Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study

Attribute

Summary statistics of the 67,145 patients in the Dutch society based on the simulated data

Min

Median

Mean (SD)

Max

Age of male

15.6

43.2

43.8 (12.2)

80.5

Age of female

15.7

43.5

44.2 (12.3)

80.4

Symptom duration (year)

0

25.2

25.1 (10.8)

78.5

Diagnosis duration (year)

0

14.3

15.9 (10.7)

54.8

BASDAI (on 1–10 scale)

0

2.66

2.97 (1.57)

8.96

BASDFI (on 1–10 scale)

0

3.86

3.93 (1.92)

9.81

  1. BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index